538965 — CONCORD DRUGS Balance Sheet
0.000.00%
- IN₹307.90m
- IN₹495.86m
- IN₹449.25m
- 18
- 66
- 34
- 31
Annual balance sheet for CONCORD DRUGS, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | C2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 0.793 | 1.01 | 1.66 | 2.4 | 2.23 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 254 | 207 | 229 | 158 | 198 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 456 | 360 | 419 | 435 | 446 |
Net Property, Plant And Equipment | 107 | 132 | 139 | 132 | 127 |
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 580 | 499 | 564 | 582 | 588 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 310 | 162 | 229 | 216 | 213 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 345 | 231 | 281 | 265 | 250 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 235 | 268 | 284 | 317 | 338 |
Total Liabilities & Shareholders' Equity | 580 | 499 | 564 | 582 | 588 |
Total Common Shares Outstanding |